News
Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround ...
Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the appointment of Aaron ...
US-based Tempus has built a precision medicine platform ... and accelerating recruitment of test subjects. The two companies have been working together for some time. In January, for example ...
Juddmonte's 'TDN Rising Star' Cosmic Year (GB) (Kingman {GB}) was rerouted from potential turf engagements in favour of Wednesday's Unibet Novice Stakes at Kempton and could not have been more ...
The addition of serial circulating tumor DNA assays to imaging surveillance offered little benefit to patients with stage II ...
DExit continued this week with the filing of a preliminary information statement by Baiyu Holdings, Inc., a company based in ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
NORTH READING, Mass., March 31, 2025--Teradyne, a leading provider of automated test equipment, has partnered with ficonTEC, a global leader in production solutions for photonics assembly and test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results